Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-23T07:24:54.393Z Has data issue: false hasContentIssue false

Increasing Resistance of Acinetobacter Species to Imipenem in United States Hospitals, 1999–2006

Published online by Cambridge University Press:  02 January 2015

Marc S. Hoffmann
Affiliation:
University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Michael R. Eber
Affiliation:
Center for Disease Dynamics, Economics & Policy, Resources for the Future, Washington, DC
Ramanan Laxminarayan*
Affiliation:
Center for Disease Dynamics, Economics & Policy, Resources for the Future, Washington, DC Princeton Environmental Institute, Princeton University, Princeton, New Jersey
*
Resources for the Future, 1616 P St NW, Ste 632, Washington, DC 20036, ([email protected])

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Research Briefs
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1.Gaynes, R, Edwards, JR. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis 2005;41:848854.Google ScholarPubMed
2.Munoz-Price, LS, Weinstein, RA. Acinetobacter infection. N Engl J Med 2008;358:12711281.Google Scholar
3.Maragakis, LL, Perl, TM. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 2008;46:12541263.CrossRefGoogle ScholarPubMed
4.Hidron, AI, Edwards, JR, Patel, J, et al.NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect Control Hosp Epidemiol 2008;29:9961011.CrossRefGoogle Scholar
5.Carey, RB, Banerjee, S, Srinivasan, A. Multidrug-resistant Acinetobacter infections, 1995-2004. In: Program and abstracts of the 46th Interscience Conference on Antimicrobial Agents and Chemotherapy; September 27-30, 2006; San Francisco, CA.Google Scholar
6.Styers, D, Sheehan, DJ, Hogan, P, Sahm, DF. Laboratory-based surveillance of current antimicrobial resistance patterns and trends among Staphylococcus aureus: 2005 status in the United States. Ann Clin Microbiol Antimicrob 2006;5:2.CrossRefGoogle ScholarPubMed
7.Sahm, DF, Marsilio, MK, Piazza, G. Antimicrobial resistance in key bloodstream bacterial isolates: electronic surveillance with The Surveillance Network Database—USA. Clin Infect Dis 1999;29:259263.CrossRefGoogle ScholarPubMed
8.Hindier, JF, Stelling, J. Analysis and presentation of cumulative antibio-grams: a new consensus guideline from the Clinical and Laboratory Standards Institute. Clin Infect Dis 2007;44:867873.CrossRefGoogle Scholar
9.Lockhart, SR, Abramson, MA, Beekmann, SE, et al.Antimicrobial resistance among gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004. J Clin Microbiol 2007;45:33523359.CrossRefGoogle ScholarPubMed
10.Kulah, C, Aktas, E, Comert, F, Ozlu, N, Akyar, I, Ankarali, H. Detecting imipenem resistance in Acinetobacter baumannii by automated systems (BD Phoenix, Microscan WalkAway, Vitek 2); high error rates with Microscan WalkAway. BMC Infect Dis 2009;9:30.CrossRefGoogle ScholarPubMed